NEXGEL delays earnings call a week to add detail on Celularity deal

NEXGEL (NASDAQ:NXGL) has rescheduled its Q4 and full-year 2025 financial results conference call to April 8, 2026, at 4:30 P.M. ET. The delay is intended to provide shareholders with more detailed information regarding its previously announced proposed transaction with Celularity Inc. The company confirmed that its Annual Report on Form 10-K for the year ended December 31, 2025, was filed with the SEC on March 31, 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments